6 completed, 1 suspended. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 6, Suspended 1 |
| Phase 2 | 2 | Completed 1, Suspended 1 |
Follow FDL169: new trials by email Literature Review of FDL169 trials Research Report on FDL169
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A DDI Study of FDL169 and FDL176 in Healthy Subjects FDL169, FDL176 - Cystic Fibrosis | Phase 1 / Phase 2 | Suspended | Flatley Discovery Lab LLC | 78 | 2018-11-27 | 2020-02-05 |
| A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects FDL169 - Cystic Fibrosis | Phase 1 | Completed | Flatley Discovery Lab LLC | 11 | 2018-04-05 | 2018-11-02 |
| An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects FDL169 - Cystic Fibrosis | Phase 1 | Completed | Flatley Discovery Lab LLC | 11 | 2017-12-18 | 2018-11-02 |
| A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects FDL169, Placebo - Cystic Fibrosis | Phase 1 | Completed | Flatley Discovery Lab LLC | 27 | 2017-08-23 | 2018-04-12 |
| Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis FDL169 - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | Flatley Discovery Lab LLC | 46 | 2016-04-01 | 2016-10-24 |
| Pharmacokinetics of FDL169 in Healthy Female Subjects FDL169 - Cystic Fibrosis | Phase 1 | Completed | Flatley Discovery Lab LLC | 8 | 2015-12-01 | 2016-03-31 |
| FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers FDL169, Placebo - Cystic Fibrosis | Phase 1 | Completed | Flatley Discovery Lab LLC | 130 | 2015-01-01 | 2016-04-08 |
Cystic Fibrosis (7)
United Kingdom (7) · Australia (1) · Czechia (1) · Germany (1)
Claudia Ordonez (1) · Claudia Ordonez, MD (1) · Khalid Abou-Farha, MBChB MD PhD (1) · Salvatore Febbraro, MD (1) · Stuart Elborn, MD (1)